<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A 21-year-old Japanese woman was referred to our hospital because of severe <z:hpo ids='HP_0001903'>anemia</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Bone marrow <z:hpo ids='HP_0002835'>aspiration</z:hpo> showed a hypercellular marrow with 91.5% promyelocytes </plain></SENT>
<SENT sid="2" pm="."><plain>Cytochemical study and surface marker a diagnosis of <z:hpo ids='HP_0004836'>acute promyelocytic leukemia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Because leukocyte count elevated, she was treated with <z:hpo ids='HP_0000001'>all</z:hpo>-trans <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> (ATRA) after conventional chemotherapy </plain></SENT>
<SENT sid="4" pm="."><plain>After 11 days of ATRA therapy, the patient started to develop severe <z:hpo ids='HP_0002315'>headache</z:hpo>, <z:hpo ids='HP_0002018'>nausea</z:hpo> and <z:hpo ids='HP_0000651'>diplopia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Ophthalmologic examination revealed bilateral <z:hpo ids='HP_0001085'>papilledema</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Computed tomography and magnetic resonance imaging of the head showed no intracranial lesion </plain></SENT>
<SENT sid="7" pm="."><plain>ATRA was discontinued because it was suspected to cause intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Her symptoms were relieved and patilledema improved gradually </plain></SENT>
<SENT sid="9" pm="."><plain>ATRA is safe and well-tolerated, if the <z:chebi fb="2" ids="26536">retinoic acid</z:chebi> syndrome can be prevented or managed </plain></SENT>
<SENT sid="10" pm="."><plain>As the tolerable dose of ATRA in adults is higher than that in children, the side effects tend to occur in children </plain></SENT>
<SENT sid="11" pm="."><plain>In Japan, only two childhood cases of intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> during ATRA therapy have been reported </plain></SENT>
<SENT sid="12" pm="."><plain>We must remember the possibility of intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> during ATRA therapy, even in adults </plain></SENT>
</text></document>